课题基金 / 基金详情

环形RNA circ_0036167通过FUS/CPEB4轴发挥抑制心肌纤维化作用的机制研究

批准号:
82070254
项目类别:
面上项目
资助金额:
55.0 万元
负责人:
单志新
依托单位:
学科分类:
心肌损伤、修复、重构和再生
结题年份:
2024
批准年份:
2020
项目状态:
已结题
项目参与者:
单志新

项目摘要

结项摘要

相似基金

相关文献

中文摘要
我们证实小鼠环形RNA circRNA_000203结合微小RNAs发挥促心肌纤维化作用(Cardiovasc Res. 2019),近期发现与之同源的人 circ_0036167在心肌纤维化时亦上调,定位于胞核,发挥抑制心肌纤维化作用。circ_0036167与融合肉瘤(FUS)RNA结合蛋白作用,解除FUS稳定胞质多糖基化元件结合蛋白4(CPEB4)mRNA作用而使CPEB4下调;CPEB4下调后TNF-α翻译受阻使Smad2/3失活。推测circ_0036167特异结合FUS,减弱FUS稳定CPEB4 mRNA作用,并降低CPEB4-TNF-α/Smad2/3活化和纤维化相关基因表达。拟建立心肌特异表达circ_0036167小鼠,从整体-细胞-分子水平阐明FUS/CPEB4轴介导circ_0036167抑制心肌纤维化的机制,为以circRNA为靶点的心肌纤维化治疗研究提供科学依据。
英文摘要
We have reported that circular RNA circRNA_000203 plays a role in cardiac remodeling via binding the related microRNAs in the cytoplasm of mouse cardiomyocytes (Cardiovasc Res, 2019). Recently, we found that the expression of homologous human circ_0036167 was increased in the myocardium of patients with heart failure and in human atrial fibroblasts exposed to Ang-II treatment. Circ_0036167 is mainly distributed in the nucleus of human atrial fibroblasts, which could inhibit the expression of fibrosis-related genes. Circ_0036167 could interact with fusion sarcoma (FUS) RNA binding protein, abolishing the effect of FUS on mRNA stability of cytoplasmic polysaccharide element binding protein 4 (CPEB4) gene, resulting in the decrease of CPEB4. Moreover, down-regulation of CPEB4 inhibited TNF-α translation, Smad2/3 activation and the expression of fibrosis-related genes in cardiac fibroblasts. We speculate that circ_0036167 can specifically bind FUS, and weaken the stabilizing effect of FUS on CPEB4 mRNA, contributing to reducing the activation of CPEB4-TNF-α/Smad2/3 signal and the expressions of CPEB4 and fibrosis-related genes. To elucidate the molecular mechanism of FUS/CPEB4 axis mediates the inhibitory effect of circ_0036167 on myocardial fibrosis on levels of body, cell and molecule, a mouse model with myocardial specific overexpression of circ_0036167 will be established and used in this project, so as to provide scientific basis and data for the treatment of myocardial fibrosis with circRNAs as the intervention targets.
非编码RNA是重要的表观遗传调节方式,参与调节心肌纤维化的病理过程。本项目证实人环形RNA circ_0036167(chr15:72244117-72302788)在心衰病人心肌和Ang-II诱导的人心房肌成纤维细胞中表达增加,且以细胞核内分布为主;利用腺病毒介导在小鼠心肌成纤维细胞(mCFs)中过表达circ_0036167可以显著抑制mCFs纤维化表型。整体动物实验结果显示心肌特异表达 circ_0036167可减轻横主动脉缩窄(TAC)手术诱导的小鼠心脏结构、功能损伤和心肌纤维化。生物信息学分析结果提示circ_0036167与RNA结合蛋白FUS有潜在的结合位点,RNA结合蛋白免疫沉淀(RIP)实验证实,circ_0036167可特异性结合FUS;功能实验证实FUS与circ_0036167可一致下调mCFs中纤维化相关COL1A1、COL3A1和α-SMA表达。mRNA表达谱和基因富集分析显示过表达circ_0036167的mCFs中细胞质聚腺苷酸化元件结合蛋白4(CPEB4)等与蛋白翻译活性相关基因表达降低。在mCFs中过表达circ_0036167可显著降低CPEB4的mRNA和蛋白水平,而RIP实验证实FUS与CPEB4的前体mRNA存在结合作用。进一步的机制研究证实CPEB4通过与Col1a1、Col3a1 以及Acta2 mRNA特异结合,增加mRNA稳定性,进而促进COL1A1、COL3A1和α-SMA蛋白表达,从而介导circ_0036167抑制心肌纤维化作用。综上,本项目证实 circ_0036167通过与融合肉瘤蛋白FUS结合并下调CPEB4表达,进而发挥抑制心肌纤维化作用,本项目为以circRNA靶点的心肌纤维化治疗研究提供了新的科学依据和资料。
国内基金
海外基金